Related Experiment Videos
Inflammation and dementia: epidemiologic evidence.
1Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Acta Neurologica Scandinavica. Supplementum
|July 27, 2006
Summary
Inflammation may contribute to cognitive disorders (CD) and neurodegeneration. While non-steroidal anti-inflammatory drugs show a protective association, the role of specific inflammatory markers and genetic factors requires further investigation in population studies.
Area of Science:
- Neuroscience
- Immunology
- Epidemiology
Background:
- Inflammation is implicated in neurodegeneration and vascular injury.
- Understanding inflammation's role in cognitive disorders (CD) is crucial for biomarker identification and genetic susceptibility assessment.
Purpose of the Study:
- To review epidemiologic studies on inflammation and cognitive disorders.
- To explore potential biomarkers and genetic factors associated with CD.
Main Methods:
- Review of epidemiologic studies measuring inflammation in relation to CD.
- Examination of associations between non-steroidal anti-inflammatory medications, serum cytokine markers, and single nucleotide polymorphisms (SNPs) with CD.
Main Results:
- Consistent inverse association reported for non-steroidal anti-inflammatory medications with CD.
- Variable reports on serum cytokine markers' association with CD.
- Limited epidemiologic data on CD and cytokine-regulating SNPs, though some clinical studies exist.
Conclusions:
- Further research is needed to clarify the role of inflammation in CD.
- Optimal methods for measuring inflammation in population-based studies require further development.